Similarly, PPARγ, a transcription factor in the PPAR protein family and a target of TZDs, diabetes drugs also known as glitazones, has beneficial effects on glycemic control while simultaneously promoting cholesterol efflux from macrophages, similar to the activity of HDL cholesterol (108, 109). Here, PPARG is linked to diabetes mellitus.